TickerKhojComparison · NSE · data 2026-11-03
Innova Captab Limited vs Senores Pharmaceuticals Ltd.
In plain words
Size: Innova Captab Limited is about 1.1 times the market value of Senores Pharmaceuticals Ltd..
Profit growth over 3 years: Senores Pharmaceuticals Ltd. 139.2% a year vs Innova Captab Limited 28.2% a year.
Debt to equity: Senores Pharmaceuticals Ltd. 0.37 vs Innova Captab Limited 0.32.
Differences in the numbers, not a recommendation of either stock.
Side by side
19 metrics shown
| INNOVACAP | SENORES | |
|---|---|---|
| Price | ₹1,003.3 | ₹1,147 |
| Market cap | ₹5,741 cr | ₹5,157 cr |
| P/E | 36.7 | 39.7 |
| P/B | — | 5.3 |
| ROE | 14.0% | 13.4% |
| ROCE | 12.9% | 12.6% |
| Debt / equity | 0.32 | 0.37 |
| Operating margin | 12.2% | 24.3% |
| Dividend yield | 0.20% | 0.00% |
| Sales growth, 3 years (yearly) | 20.1% | 161.6% |
| Profit growth, 3 years (yearly) | 28.2% | 139.2% |
| 1-year return | 22.0% | 48.7% |
| Revenue, last 12 months | ₹1,749 cr | ₹722 cr |
| Net profit, last 12 months | ₹156 cr | ₹133 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹44 cr | ₹39 cr |
| Quarter profit vs a year earlier | +42.3% | +22.0% |
| Promoter holding | 50.90% | 45.82% |
| Health check | Strong (7.4/10) | Strong (7.2/10) |
Common questions
Which has a higher P/E, Innova Captab Limited or Senores Pharmaceuticals Ltd.?
Senores Pharmaceuticals Ltd. trades at the higher P/E (39.7 against 36.7). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Innova Captab Limited (14.0% against 13.4%).
Which carries more debt?
Senores Pharmaceuticals Ltd. has the higher debt-to-equity ratio (0.37 against 0.32).